Clinical Trial: Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections
Study Status: Completed
Recruit Status: RECRUITING
Condition: Retinal Disease
Study Type: INTERVENTIONAL
Official Title: Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Pain and Corneal Epitheliopathy
Brief Summary:
This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections.
Read more